Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Interferon alfacon-1
DRUG
2 trials
Sponsors
Astellas Pharma Inc
, University Health Network, Toronto
Conditions
Hepatitis C
Influenza
Phase 1
Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza
NCT01227798
University Health Network, Toronto
Influenza
Start: 2010-11-30
End: 2011-11-30
Target: 30
Updated: 2010-10-25
Phase 3
Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C
Completed
NCT00239252
Astellas Pharma Inc
Hepatitis C
Updated: 2014-08-26